How long ssDNA is made.
The production route determines which variants, intermediates and carryover must be measured.
Stepwise yield compounds.
At 99.5% coupling efficiency, 200 coupling steps give a theoretical 36.7% full-length fraction before purification. This arithmetic is not an assay of the delivered material.
Failed coupling, capping and subsequent processing affect the impurity profile. Ask for full-length content at your requested length and the analytical method used to establish it.
Compare the route. Specify the product.
| Production route | Error behaviour | How the single strand is obtained | What has to be specified |
|---|---|---|---|
| Thermocycled amplification | Polymerase errors can produce a heterogeneous variant population. Routine size purification does not establish sequence correctness. | Process-dependent: for example, strand separation after duplex amplification or asymmetric amplification. | Polymerase, effective doublings, product variant burden, residual dsDNA and assay sensitivity. |
| Strand-displacement amplification | Displaced 3′ ends can re-prime elsewhere. This chimera mechanism was characterised in an MDA workflow; it is not a universal rate for RCA. | Depends on the reaction architecture and downstream processing. | Rearrangement assessment with a sequence-resolved method, such as long-read sequencing; residual dsDNA. |
| Strand separation from duplex | Inherits upstream sequence variants; separation is not sequence verification. | For example, exonuclease digestion or affinity capture. Residual complementary material must be measured. | Residual dsDNA fraction, its size distribution, assay and limit of detection. |
| Bacterial or phage production | Host and construct selection affect sequence stability and compatibility. | Production and recovery from the biological system. | Sequence identity, endotoxin, host DNA and RNA carryover. |
| Solid-phase chemical synthesis | Coupling losses compound. At 99.5% per step, 200 steps give a theoretical 36.7% full-length fraction before purification. | Single-stranded synthesis, followed by cleavage, deprotection and purification. | Full-length content at the delivered length, truncation profile and analytical method. |
| Moligo enzymatic synthesis | Isothermal rolling-circle amplification from a sequence-verified production template. Product characterisation is agreed per project. | Agreed per project. | Incorporated chemistry and fraction, strand format, full-length content, residual dsDNA and measurement methods. |
Chimera mechanism: Lasken and Stockwell, BMC Biotechnology 2007;7:19. Coupling arithmetic: 0.995200 = 36.7%. This is a theoretical pre-purification model, not a delivered-purity specification. Route descriptions do not establish Moligo performance relative to another supplier.
The specification comes first.
For enzymatic synthesis, the template, polymerase, reaction history and downstream process all matter. A sequence-verified template is the starting point; it is not a per-molecule measurement of the final preparation.
Compare supplier specifications